India rates: Dovish signals in the offing
RBI could turn more dovish.
Group Research - Econs, Radhika Rao4 Dec 2024
Article image
Photo credit: Unsplash/Adobe Stock Photo
Read More

A notable miss in 2QFY25 (3Q) real GDP growth last week has put the central bank’s full year forecast of 7.2% yoy at risk. Even as this GDP print likely marked the bottom of the cycle, and we look for a modest recovery in the second half, FY25 growth is on course to settle in a lower 6.2-6.4% range compared to the previous 6.7-7.0% (read the review here). On the other hand, inflation has been at the upper end of the target range in the past two months, with October’s 6.2% marking the fastest pace of rise in over a year and a half (read details here). Bulk of the increase was on account of higher food prices, which triggered a debate on whether policymakers should consider headline CPI excluding-food to get a handle on the underlying price momentum. Despite an anticipated moderation in November’s inflation, 3QFY (4Q24) average will be at least 60-70bp above the RBI’s 4.8% projection for the quarter. This growth-inflation divergence will put the RBI monetary policy committee (MPC) in a bind ahead of Friday’s policy meeting.

We expect the official growth projection at 7.2% to be lowered by 30-40bp and inflation to be raised by 10-20bp from the current 4.5%. Ahead of the growth undershoot, the MPC had maintained a cautious posture, highlighting limited room to cut rates in the face of above-target inflation. With inflation running above target but expected to moderate going forward, we expect a dovish hold from the MPC, with more members voting for a cut compared to 5:1 ratio at the last review. A rate cut is more likely at the February 2025 meeting. Still there is a small probability that the recent GDP miss might have convinced the MPC to shift to a growth supportive stance and bring forward the rate cut to December.

Liquidity and rupee are the two other areas of focus. From a surplus balance in the past two months, liquidity conditions had tightened due to GST outflows, a likely negative BOP balance in the quarter and stepped-up FX intervention. The upcoming outflow of advance tax collections around mid-month is likely to widen the deficit anew. Hence, authorities might explore available options, including either relying on ad hoc money market operations or choosing an alternative between a (permanent injection via) CRR cut, or buy-sell swaps as a sterilisation tool. We see a little more than even probability of a 25bp cut in the CRR (outside chance of 50bp). The rupee is meanwhile under pressure from USD strength and portfolio outflows. The notable drop in foreign reserves in the past fortnight highlights the scale of intervention that was required to keep the currency from breaking through fresh successive lows.

Nonetheless, one can argue that the strong build up in reserves was precisely to ‘save for this rainy day’. Pressure might also build from indications that intervention efforts have led the central bank’s aggregate short FCY in forwards and futures position to rise sharply in October and expected to climb by another $15-20bn in November. Strong official presence has supported the currency, with the INR down only -1.8% on YTD terms, amongst the better performers in the region. In a high US yield environment, a rate cut might narrow rate differentials further, creating further pressure on the INR.


Radhika Rao

Senior Economist – Eurozone, India, Indonesia
[email protected]



Subscribe here to receive our economics & macro strategy materials.
To unsubscribe, please click here.

Topic

GENERAL DISCLOSURE/ DISCLAIMER (For Macroeconomics, Currencies, Interest Rates)

GENERAL DISCLOSURE/ DISCLAIMER (For Macroeconomics, Currencies, Interest Rates)

The information herein is published by DBS Bank Ltd and/or DBS Bank (Hong Kong) Limited (each and/or collectively, the “Company”). It is based on information obtained from sources believed to be reliable, but the Company does not make any representation or warranty, express or implied, as to its accuracy, completeness, timeliness or correctness for any particular purpose. Opinions expressed are subject to change without notice. This research is prepared for general circulation.  Any recommendation contained herein does not have regard to the specific investment objectives, financial situation and the particular needs of any specific addressee. The information herein is published for the information of addressees only and is not to be taken in substitution for the exercise of judgement by addressees, who should obtain separate legal or financial advice. The Company, or any of its related companies or any individuals connected with the group accepts no liability for any direct, special, indirect, consequential, incidental damages or any other loss or damages of any kind arising from any use of the information herein (including any error, omission or misstatement herein, negligent or otherwise) or further communication thereof, even if the Company or any other person has been advised of the possibility thereof. The information herein is not to be construed as an offer or a solicitation of an offer to buy or sell any securities, futures, options or other financial instruments or to provide any investment advice or services. The Company and its associates, their directors, officers and/or employees may have positions or other interests in, and may effect transactions in securities mentioned herein and may also perform or seek to perform broking, investment banking and other banking or financial services for these companies.  The information herein is not directed to, or intended for distribution to or use by, any person or entity that is a citizen or resident of or located in any locality, state, country, or other jurisdiction (including but not limited to citizens or residents of the United States of America) where such distribution, publication, availability or use would be contrary to law or regulation.  The information is not an offer to sell or the solicitation of an offer to buy any security in any jurisdiction (including but not limited to the United States of America) where such an offer or solicitation would be contrary to law or regulation.

[#for Distribution in Singapore] This report is distributed in Singapore by DBS Bank Ltd (Company Regn. No. 196800306E) which is Exempt Financial Advisers as defined in the Financial Advisers Act and regulated by the Monetary Authority of Singapore. DBS Bank Ltd may distribute reports produced by its respective foreign entities, affiliates or other foreign research houses pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, DBS Bank Ltd accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact DBS Bank Ltd at 65-6878-8888 for matters arising from, or in connection with the report.

DBS Bank Ltd., 12 Marina Boulevard, Marina Bay Financial Centre Tower 3, Singapore 018982. Tel: 65-6878-8888. Company Registration No. 196800306E.

DBS Bank Ltd., Hong Kong Branch, a company incorporated in Singapore with limited liability. 18th Floor, The Center, 99 Queen’s Road Central, Central, Hong Kong SAR.

DBS Bank (Hong Kong) Limited, a company incorporated in Hong Kong with limited liability.  11th Floor, The Center, 99 Queen’s Road Central, Central, Hong Kong SAR.

Virtual currencies are highly speculative digital "virtual commodities", and are not currencies. It is not a financial product approved by the Taiwan Financial Supervisory Commission, and the safeguards of the existing investor protection regime does not apply.  The prices of virtual currencies may fluctuate greatly, and the investment risk is high. Before engaging in such transactions, the investor should carefully assess the risks, and seek its own independent advice.